Cell Expansion Global Market - Forecast to 2022
Cell expansion technology has been emerging as a promising therapeutic solution for many diseases and is used for engineering, replacing, or regenerating human tissues, cells, and organs to restore normal function. Products of cell expansion market are segmented into instruments and consumables. The instruments are segmented into cell expansion supporting instruments, bioreactors and automatic cell expansion systems. Cell expansion supporting equipments include flow cytometer, centrifuge, cell counters and others. Bioreactors are segmented into stirred type bioreactors, microcarrier-based anchorage-dependent stirred type bioreactors, suspension-based anchorage independent stirred type bioreactors, hollow fibre/perfusion bioreactors, bubble column and airlift bioreactor, single/disposable use bioreactor and others. Consumables are segmented into reagents, media, sera and disposables. Disposables are further sub-segmented into culture vessels, bioreactor accessories and others.
By cell types, the cell expansion markets are divided into animal cells, human cells, bacterial cells and others. The human cell includes adult stem cells, induced pluripotent stem cells and embryonic stem cells. Adult stem cells are segmented into mesenchymal stem cells, hematopoietic stem cells and neural stem cells. Others include yeast cells and insect cells.
By application, the cell expansion markets are divided into regenerative medicine and stem cell research, cancer studies and others. The end users of the cell expansion market are segmented into academics and research institutes, biotechnology and biopharmaceutical companies, hospital, biobanks and others.
Among the cell expansion products, the consumables dominated the market by occupying a largest share and instruments market is estimated to be the fastest growing segment from 2015 to 2022. In cell types, human cell types is the largest segment as well as the fastest growing segment. In applications, the regenerative medicine and stem cell research is the largest segment and is the fastest growing segment with a highest CAGR of 18.1% from 2015-2022. By end- users, hospitals and bio banks are the largest segment with a share of 37.0% and also, the fastest segment from 2015 to 2022.
Geographically, North America is the largest market followed by Europe and Asia. The APAC region is the fastest growing region with a CAGR of 20.8% from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the cell expansion market. Growth in the Asian market is attributed to rising prevalence of chronic diseases and increased government initiatives for stem cell research.
The cell expansion market is expected to grow at a double digit CAGR to reach $23,997 million by 2022. Rising prevalence of chronic diseases, increasing government funding for research, increased investments in cell based products, growing number of GMP-certified production facilities and 3D cell expansion technology are some of the drivers in the cell expansion global market. High cost of cell-based research, use of unregulated products, quality issues for end users, ethical concerns regarding research on cell biology and stringent regulation are some of the factors hampering the market.
The cell expansion global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the cell expansion market are Becton Dickinson and Company (U.S.), Corning, Inc. (U.S.), Danaher Corporation (U.S.), Eppendorf AG (Germany), GE Healthcare (U.K), Lonza Group Ltd. (Switzerland), Merck KGAA (Germany.), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Terumo Corporation (Japan) and ThermoFisher Scientific Inc. (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
By cell types, the cell expansion markets are divided into animal cells, human cells, bacterial cells and others. The human cell includes adult stem cells, induced pluripotent stem cells and embryonic stem cells. Adult stem cells are segmented into mesenchymal stem cells, hematopoietic stem cells and neural stem cells. Others include yeast cells and insect cells.
By application, the cell expansion markets are divided into regenerative medicine and stem cell research, cancer studies and others. The end users of the cell expansion market are segmented into academics and research institutes, biotechnology and biopharmaceutical companies, hospital, biobanks and others.
Among the cell expansion products, the consumables dominated the market by occupying a largest share and instruments market is estimated to be the fastest growing segment from 2015 to 2022. In cell types, human cell types is the largest segment as well as the fastest growing segment. In applications, the regenerative medicine and stem cell research is the largest segment and is the fastest growing segment with a highest CAGR of 18.1% from 2015-2022. By end- users, hospitals and bio banks are the largest segment with a share of 37.0% and also, the fastest segment from 2015 to 2022.
Geographically, North America is the largest market followed by Europe and Asia. The APAC region is the fastest growing region with a CAGR of 20.8% from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the cell expansion market. Growth in the Asian market is attributed to rising prevalence of chronic diseases and increased government initiatives for stem cell research.
The cell expansion market is expected to grow at a double digit CAGR to reach $23,997 million by 2022. Rising prevalence of chronic diseases, increasing government funding for research, increased investments in cell based products, growing number of GMP-certified production facilities and 3D cell expansion technology are some of the drivers in the cell expansion global market. High cost of cell-based research, use of unregulated products, quality issues for end users, ethical concerns regarding research on cell biology and stringent regulation are some of the factors hampering the market.
The cell expansion global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the cell expansion market are Becton Dickinson and Company (U.S.), Corning, Inc. (U.S.), Danaher Corporation (U.S.), Eppendorf AG (Germany), GE Healthcare (U.K), Lonza Group Ltd. (Switzerland), Merck KGAA (Germany.), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Terumo Corporation (Japan) and ThermoFisher Scientific Inc. (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Rising Prevalence of Chronic Diseases
3.3.1.2 Increasing Government Funding for Research
3.3.1.3 Increased Investments in Cell Based Research
3.3.1.4 Growing Number of GMP-Certified Production Facilities.
3.3.1.5 3D Cell Expansion Technology
3.3.1.6 Countries in Asia-Pacific Region to Present High-Growth Opportunities
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 High Cost of Cell-Based Products
3.3.2.2 Use of Unregulated Products
3.3.2.3 Quality Issues for End Users
3.3.2.4 Ethical Concerns Regarding Research on Cell Biology
3.3.2.5 Stringent Regulation
3.4 PORTER’S FIVE FORCE ANALYSIS
3.4.1 THREAT OF NEW ENTRANTS
3.4.2 THREAT OF SUBSTITUTES
3.4.3 BARGAINING POWER OF SUPPLIERS
3.4.4 BARGAINING POWER OF BUYERS
3.4.5 COMPETITIVE RIVALRY
3.5 REGULATORY GUIDELINES
3.5.1 U.S.
3.5.2 EUROPE
3.5.3 INDIA
3.5.4 CHINA
3.5.5 JAPAN
3.6 UPCOMING TECHNOLOGIES
3.7 SUPPLY CHAIN ANALYSIS
3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.8.1 CELL EXPANSION GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015
3.8.2 SINGLE-USE BIOREACTOR MARKET REVENUE, BY MAJOR PLAYERS, 2015
3.9 PATENT TRENDS
4 CELL EXPANSION GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 INSTRUMENTS
4.2.1 CELL EXPANSION SUPPORTING EQUIPMENTS
4.2.1.1 Flow Cytometers
4.2.1.2 Centrifuge
4.2.1.3 Cell Counters
4.2.1.4 Other Cell Expansion Supporting Equipments
4.2.2 BIOREACTORS
4.2.2.1 Stirred Type Bioreactors
4.2.2.2 Microcarrier-Based Anchorage-Dependent Stirred Type Bioreactors
4.2.2.3 Suspension-Based Anchorage Independent Stirred Type Bioreactors
4.2.2.4 Hollow Fiber/Perfusion Bioreactors
4.2.2.5 Bubble Column And Airlift Bioreactors
4.2.2.6 Single Use/Disposabable Bioreactors
4.2.2.7 Other Bioreactors
4.2.3 AUTOMATED CELL EXPANSION SYSTEMS
4.3 CONSUMABLES
4.3.1 REAGENTS, MEDIA AND SERA
4.3.2 DISPOSABLES
4.3.2.1 Culture Vessels
4.3.2.2 Bioreactor Accessories
4.3.2.3 Others
5 CELL EXPANSION MARKET, BY TYPES
5.1 INTRODUCTION
5.2 ANIMAL CELL
5.3 HUMAN CELL
5.3.1 ADULT STEM CELL
5.3.1.1 Neural Stem Cells (NSCs)
5.3.1.2 Hematopoietic Stem Cells (HSCs)
5.3.1.3 Mesenchymal Stem Cells (MSC)
5.3.2 INDUCED PLURIPOTENT STEM CELL (IPSC)
5.3.3 EMBRYONIC STEM CELL
5.4 BACTERIAL CELLS
5.5 OTHERS
6 CELL EXPANSION GLOBAL MARKET, BY APPLICATIONS
6.1 INTRODUCTION
6.2 REGENERATIVE MEDICINE AND STEM CELL RESEARCH
6.3 CANCER STUDIES
6.4 OTHERS
7 CELL EXPANSION GLOBAL MARKET, BY END USERS
7.1 INTRODUCTION
7.2 ACADEMIC AND RESEARCH INSTITUTES
7.3 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANY
7.4 HOSPITALS AND BIO BANKS
7.5 OTHERS
8 REGIONAL MARKET ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.3 EUROPE
8.4 ASIA PACIFIC
8.5 REST OF THE WORLD
9 COMPANY DEVELOPMENTS
9.1 INTRODUCTION
9.1.1 NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF CELL EXPANSION MARKET PLAYERS
9.2 NEW PRODUCT LAUNCH
9.3 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES
9.4 OTHER DEVELOPMENTS
9.5 MERGER AND ACQISITION
10 COMPANY PROFILE
10.1 BECTON, DICKINSON AND COMPANY (CAREFUSION CORPORATION)
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 CORNING, INC.
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 DANAHER CORPORATION
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 EPPENDORF AG
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 GE HEALTHCARE
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 LONZA GROUP LTD.
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 MERCK KGAA
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 MILTENYI BIOTEC GMBH
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 STEMCELL TECHNOLOGIES
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 TERUMO CORPORATION
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
10.11 THERMOFISHER SCIENTIFIC, INC.
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.3 PRODUCT PORTFOLIO
10.11.4 KEY DEVELOPMENTS
10.11.5 BUSINESS STRATEGY
10.11.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Rising Prevalence of Chronic Diseases
3.3.1.2 Increasing Government Funding for Research
3.3.1.3 Increased Investments in Cell Based Research
3.3.1.4 Growing Number of GMP-Certified Production Facilities.
3.3.1.5 3D Cell Expansion Technology
3.3.1.6 Countries in Asia-Pacific Region to Present High-Growth Opportunities
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 High Cost of Cell-Based Products
3.3.2.2 Use of Unregulated Products
3.3.2.3 Quality Issues for End Users
3.3.2.4 Ethical Concerns Regarding Research on Cell Biology
3.3.2.5 Stringent Regulation
3.4 PORTER’S FIVE FORCE ANALYSIS
3.4.1 THREAT OF NEW ENTRANTS
3.4.2 THREAT OF SUBSTITUTES
3.4.3 BARGAINING POWER OF SUPPLIERS
3.4.4 BARGAINING POWER OF BUYERS
3.4.5 COMPETITIVE RIVALRY
3.5 REGULATORY GUIDELINES
3.5.1 U.S.
3.5.2 EUROPE
3.5.3 INDIA
3.5.4 CHINA
3.5.5 JAPAN
3.6 UPCOMING TECHNOLOGIES
3.7 SUPPLY CHAIN ANALYSIS
3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.8.1 CELL EXPANSION GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015
3.8.2 SINGLE-USE BIOREACTOR MARKET REVENUE, BY MAJOR PLAYERS, 2015
3.9 PATENT TRENDS
4 CELL EXPANSION GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 INSTRUMENTS
4.2.1 CELL EXPANSION SUPPORTING EQUIPMENTS
4.2.1.1 Flow Cytometers
4.2.1.2 Centrifuge
4.2.1.3 Cell Counters
4.2.1.4 Other Cell Expansion Supporting Equipments
4.2.2 BIOREACTORS
4.2.2.1 Stirred Type Bioreactors
4.2.2.2 Microcarrier-Based Anchorage-Dependent Stirred Type Bioreactors
4.2.2.3 Suspension-Based Anchorage Independent Stirred Type Bioreactors
4.2.2.4 Hollow Fiber/Perfusion Bioreactors
4.2.2.5 Bubble Column And Airlift Bioreactors
4.2.2.6 Single Use/Disposabable Bioreactors
4.2.2.7 Other Bioreactors
4.2.3 AUTOMATED CELL EXPANSION SYSTEMS
4.3 CONSUMABLES
4.3.1 REAGENTS, MEDIA AND SERA
4.3.2 DISPOSABLES
4.3.2.1 Culture Vessels
4.3.2.2 Bioreactor Accessories
4.3.2.3 Others
5 CELL EXPANSION MARKET, BY TYPES
5.1 INTRODUCTION
5.2 ANIMAL CELL
5.3 HUMAN CELL
5.3.1 ADULT STEM CELL
5.3.1.1 Neural Stem Cells (NSCs)
5.3.1.2 Hematopoietic Stem Cells (HSCs)
5.3.1.3 Mesenchymal Stem Cells (MSC)
5.3.2 INDUCED PLURIPOTENT STEM CELL (IPSC)
5.3.3 EMBRYONIC STEM CELL
5.4 BACTERIAL CELLS
5.5 OTHERS
6 CELL EXPANSION GLOBAL MARKET, BY APPLICATIONS
6.1 INTRODUCTION
6.2 REGENERATIVE MEDICINE AND STEM CELL RESEARCH
6.3 CANCER STUDIES
6.4 OTHERS
7 CELL EXPANSION GLOBAL MARKET, BY END USERS
7.1 INTRODUCTION
7.2 ACADEMIC AND RESEARCH INSTITUTES
7.3 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANY
7.4 HOSPITALS AND BIO BANKS
7.5 OTHERS
8 REGIONAL MARKET ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.3 EUROPE
8.4 ASIA PACIFIC
8.5 REST OF THE WORLD
9 COMPANY DEVELOPMENTS
9.1 INTRODUCTION
9.1.1 NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF CELL EXPANSION MARKET PLAYERS
9.2 NEW PRODUCT LAUNCH
9.3 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES
9.4 OTHER DEVELOPMENTS
9.5 MERGER AND ACQISITION
10 COMPANY PROFILE
10.1 BECTON, DICKINSON AND COMPANY (CAREFUSION CORPORATION)
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 CORNING, INC.
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 DANAHER CORPORATION
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 EPPENDORF AG
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 GE HEALTHCARE
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 LONZA GROUP LTD.
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 MERCK KGAA
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 MILTENYI BIOTEC GMBH
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 STEMCELL TECHNOLOGIES
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 TERUMO CORPORATION
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
10.11 THERMOFISHER SCIENTIFIC, INC.
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.3 PRODUCT PORTFOLIO
10.11.4 KEY DEVELOPMENTS
10.11.5 BUSINESS STRATEGY
10.11.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 CELL EXPANSION GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 2 CELL EXPANSION GLOBAL MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
Table 3 CELL EXPANSION GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 4 CELL EXPANSION GLOBAL MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
Table 5 CELL EXPANSION GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 6 CELL EXPANSION INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 7 CELL EXPANSION INSTRUMENTS GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 8 CELL EXPANSION SUPPORTING EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 9 CELL EXPANSION SUPPORTING EQUIPMENTS GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 10 FLOW CYTOMETER GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 11 CENTRIFUGE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 12 CELL COUNTER GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 13 OTHER CELL EXPANSION SUPPORTING EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 14 BIOREACTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 15 BIOREACTORS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 16 STIRRED TYPE BIOREACTORS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 17 MICROCARRIER-BASED ANCHORAGE-DEPENDENT STIRRED TYPE BIOREACTORS GLOBALMARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 18 SUSPENSION-BASED ANCHORAGE INDEPENDENT STIRRED TYPE BIOREACTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 19 HOLLOW FIBER PERFUSION BIOREACTORS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 20 BUBBLE COLUMN AND AIRLIFT BIOREACTOR GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 21 SINGLE USE/DISPOSABLE BIOREACTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 22 OTHER BIOREACTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 23 AUTOMATED CELL EXPANSION SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 24 CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 25 CONSUMABLES GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 26 REAGENTS, MEDIA AND SERA GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 27 DISPOSABLES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 28 DISPOSABLES GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 29 CULTURE VESSELS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 30 BIOREACTOR ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 31 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 32 CELL EXPANSION GLOBAL MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
Table 33 ANIMAL CELL GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 34 HUMAN CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 35 HUMAN CELL GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 36 ADULT STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 37 ADULT STEM CELL GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 38 NEURAL STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 39 HEMATOPOITIC STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 40 MESENCHYMAL STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 41 INDUCED PLURIPOTENT STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 42 EMBRYONIC STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 43 BACTERIAL CELLS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 44 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 45 CELL EXPANSION GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 46 REGENRATIVE MEDICINE AND STEM CELL RESEARCH APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 47 CANCER STUDIES APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 48 OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 49 CELL EXPANSION GLOBAL MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
Table 50 ACADEMIC AND RESEARCH INSTITUTE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 51 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 52 HOSPITALS AND BIO BANKS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 53 OTHER END USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 54 NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 55 NORTH AMERICA CELL EXPANSION INSTRUMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 56 NORTH AMERICA CELL EXPANSION SUPPORTING EQUIPMENTS GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 57 NORTH AMERICA CELL EXPANSION BIOREACTORS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 58 NORTH AMERICA CELL EXPANSION CONSUMABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 59 NORTH AMERICA CELL EXPANSION DISPOSABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 60 NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
Table 61 NORTH AMERICA HUMAN CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 62 NORTH AMERICA ADULT STEM CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 63 NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 64 NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
Table 65 EUROPEAN CELL EXPANSION MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 66 EUROPEAN CELL EXPANSION INSTRUMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 67 EUROPEAN CELL EXPANSION SUPPORTING EQUIPMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 68 EUROPEAN CELL EXPANSION BIOREACTORS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 69 EUROPEAN CELL EXPANSION CONSUMABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 70 EUROPEAN CELL EXPANSION DISPOSABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 71 EUROPEAN CELL EXPANSION MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
Table 72 EUROPEAN HUMAN CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 73 EUROPEAN ADULT STEM CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 74 EUROPEAN CELL EXPANSION MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 75 EUROPEAN CELL EXPANSION MARKET REVENUE, BY END USERS , (2014-2022) ($MN)
Table 76 ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 77 ASIA PACIFIC CELL EXPANSION INSTRUMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 78 ASIA PACIFIC CELL EXPANSION SUPPORTING EQUIPMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 79 ASIA PACIFIC CELL EXPANSION BIOREACTORS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 80 ASIA PACIFIC CELL EXPANSION CONSUMABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 81 ASIA PACIFIC CELL EXPANSION DISPOSABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 82 ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
Table 83 ASIA PACIFIC HUMAN CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 84 ASIA PACIFIC ADULT STEM CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 85 ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 86 ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY END USERS , (2014-2022) ($MN)
Table 87 ROW CELL EXPANSION MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 88 ROW CELL EXPANSION INSTRUMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 89 ROW CELL EXPANSION SUPPORTING EQUIPMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 90 ROW CELL EXPANSION BIOREACTORS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 91 ROW CELL EXPANSION CONSUMABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 92 ROW CELL EXPANSION DISPOSABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 93 ROW CELL EXPANSION MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
Table 94 ROW HUMAN CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 95 ROW ADULT STEM CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 96 ROW CELL EXPANSION MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 97 ROW CELL EXPANSION MARKET REVENUE, BY END USERS , (2014-2022) ($MN)
Table 98 NEW PRODUCT LAUNCH (2014-2016)
Table 99 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2014-2016)
Table 100 OTHERS (2014-2016)
Table 101 MERGER AND ACQUISITION (2014-2016)
Table 102 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 103 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 104 BECTON DIKINSON AND COMPANY: LIFE SCIENCE REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 105 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 106 CORNING, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 107 CORNING, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 108 CORNING, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 109 DANAHER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 110 DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 111 DANAHER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 112 EPPENDORF AG: TOTAL REVENUE AND R&D EXPENSES (2013-2015) ($MN)
Table 113 EPPENDORF AG: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 114 GE: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 115 GE: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 116 GE: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 117 LONZA GROUP LTD.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 118 LONZA GROUP LTD.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 119 LONZA GROUP LTD.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 120 MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 121 MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 122 MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 123 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 124 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 125 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 126 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 127 THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 128 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 1 CELL EXPANSION GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 2 CELL EXPANSION GLOBAL MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
Table 3 CELL EXPANSION GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 4 CELL EXPANSION GLOBAL MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
Table 5 CELL EXPANSION GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 6 CELL EXPANSION INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 7 CELL EXPANSION INSTRUMENTS GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 8 CELL EXPANSION SUPPORTING EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 9 CELL EXPANSION SUPPORTING EQUIPMENTS GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 10 FLOW CYTOMETER GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 11 CENTRIFUGE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 12 CELL COUNTER GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 13 OTHER CELL EXPANSION SUPPORTING EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 14 BIOREACTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 15 BIOREACTORS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 16 STIRRED TYPE BIOREACTORS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 17 MICROCARRIER-BASED ANCHORAGE-DEPENDENT STIRRED TYPE BIOREACTORS GLOBALMARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 18 SUSPENSION-BASED ANCHORAGE INDEPENDENT STIRRED TYPE BIOREACTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 19 HOLLOW FIBER PERFUSION BIOREACTORS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 20 BUBBLE COLUMN AND AIRLIFT BIOREACTOR GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 21 SINGLE USE/DISPOSABLE BIOREACTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 22 OTHER BIOREACTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 23 AUTOMATED CELL EXPANSION SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 24 CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 25 CONSUMABLES GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 26 REAGENTS, MEDIA AND SERA GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 27 DISPOSABLES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 28 DISPOSABLES GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 29 CULTURE VESSELS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 30 BIOREACTOR ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 31 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 32 CELL EXPANSION GLOBAL MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
Table 33 ANIMAL CELL GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 34 HUMAN CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 35 HUMAN CELL GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 36 ADULT STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 37 ADULT STEM CELL GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 38 NEURAL STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 39 HEMATOPOITIC STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 40 MESENCHYMAL STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 41 INDUCED PLURIPOTENT STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 42 EMBRYONIC STEM CELL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 43 BACTERIAL CELLS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 44 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 45 CELL EXPANSION GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 46 REGENRATIVE MEDICINE AND STEM CELL RESEARCH APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 47 CANCER STUDIES APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 48 OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 49 CELL EXPANSION GLOBAL MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
Table 50 ACADEMIC AND RESEARCH INSTITUTE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 51 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 52 HOSPITALS AND BIO BANKS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 53 OTHER END USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 54 NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 55 NORTH AMERICA CELL EXPANSION INSTRUMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 56 NORTH AMERICA CELL EXPANSION SUPPORTING EQUIPMENTS GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 57 NORTH AMERICA CELL EXPANSION BIOREACTORS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 58 NORTH AMERICA CELL EXPANSION CONSUMABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 59 NORTH AMERICA CELL EXPANSION DISPOSABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 60 NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
Table 61 NORTH AMERICA HUMAN CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 62 NORTH AMERICA ADULT STEM CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 63 NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 64 NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
Table 65 EUROPEAN CELL EXPANSION MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 66 EUROPEAN CELL EXPANSION INSTRUMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 67 EUROPEAN CELL EXPANSION SUPPORTING EQUIPMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 68 EUROPEAN CELL EXPANSION BIOREACTORS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 69 EUROPEAN CELL EXPANSION CONSUMABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 70 EUROPEAN CELL EXPANSION DISPOSABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 71 EUROPEAN CELL EXPANSION MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
Table 72 EUROPEAN HUMAN CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 73 EUROPEAN ADULT STEM CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 74 EUROPEAN CELL EXPANSION MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 75 EUROPEAN CELL EXPANSION MARKET REVENUE, BY END USERS , (2014-2022) ($MN)
Table 76 ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 77 ASIA PACIFIC CELL EXPANSION INSTRUMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 78 ASIA PACIFIC CELL EXPANSION SUPPORTING EQUIPMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 79 ASIA PACIFIC CELL EXPANSION BIOREACTORS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 80 ASIA PACIFIC CELL EXPANSION CONSUMABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 81 ASIA PACIFIC CELL EXPANSION DISPOSABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 82 ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
Table 83 ASIA PACIFIC HUMAN CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 84 ASIA PACIFIC ADULT STEM CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 85 ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 86 ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY END USERS , (2014-2022) ($MN)
Table 87 ROW CELL EXPANSION MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 88 ROW CELL EXPANSION INSTRUMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 89 ROW CELL EXPANSION SUPPORTING EQUIPMENTS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 90 ROW CELL EXPANSION BIOREACTORS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 91 ROW CELL EXPANSION CONSUMABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 92 ROW CELL EXPANSION DISPOSABLES MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 93 ROW CELL EXPANSION MARKET REVENUE, BY CELL TYPES, (2014-2022) ($MN)
Table 94 ROW HUMAN CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 95 ROW ADULT STEM CELL EXPANSION MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 96 ROW CELL EXPANSION MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 97 ROW CELL EXPANSION MARKET REVENUE, BY END USERS , (2014-2022) ($MN)
Table 98 NEW PRODUCT LAUNCH (2014-2016)
Table 99 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2014-2016)
Table 100 OTHERS (2014-2016)
Table 101 MERGER AND ACQUISITION (2014-2016)
Table 102 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 103 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 104 BECTON DIKINSON AND COMPANY: LIFE SCIENCE REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 105 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 106 CORNING, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 107 CORNING, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 108 CORNING, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 109 DANAHER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 110 DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 111 DANAHER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 112 EPPENDORF AG: TOTAL REVENUE AND R&D EXPENSES (2013-2015) ($MN)
Table 113 EPPENDORF AG: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 114 GE: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 115 GE: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 116 GE: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 117 LONZA GROUP LTD.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 118 LONZA GROUP LTD.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 119 LONZA GROUP LTD.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 120 MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 121 MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 122 MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 123 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 124 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 125 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 126 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 127 THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 128 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
LIST OF FIGURES
Figure 1 CELL EXPANSION GLOBAL MARKET, BY REGION (2014-2022) ($MN)
Figure 2 RESEARCH METHODOLOGY: CELL EXPANSION GLOBAL MARKET
Figure 3 CELL EXPANSION GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 CELL EXPANSION GLOBAL MARKET: FORECASTING MODEL
Figure 5 CELL EXPANSION GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
Figure 6 CELL EXPANSION GLOBAL MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 CELL EXPANSION GLOBAL MARKET: PORTER’S ANALYSIS
Figure 9 CELL EXPANSION GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
Figure 10 CELL EXPANSION GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015, (%)
Figure 11 SINGLE-USE BIOREACTOR MARKET REVENUE, BY MAJOR PLAYERS, 2015, (%)
Figure 12 CELL EXPANSION GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
Figure 13 CELL EXPANSION GLOBAL MARKET, BY PRODUCTS, (2014-2022) ($MN)
Figure 14 CELL EXPANSION INSTRUMENTS GLOBAL MARKET, BY TYPE, (2014-2022) ($MN)
Figure 15 CELL EXPANSION SUPPORTING EQUIPMENTSS GLOBAL MARKET, BY TYPE (2014-2022) ($MN)
Figure 16 CELL EXPANSION BIOREACTORS GLOBAL MARKET, BY TYPE, (2015 V’S 2022), ($MN)
Figure 17 CELL EXPANSION CONSUMABLES GLOBAL MARKET, BY TYPE, (2014-2022), ($MN)
Figure 18 CELL EXPANSION DISPOSABLES GLOBAL MARKET, BY TYPE, (2014-2022) ($MN)
Figure 19 CELL EXPANSION GLOBAL MARKET, BY CELL TYPES, (2015 V’S 2022) ($MN)
Figure 20 HUMAN CELL GLOBAL MARKET, BY TYPE, (2015 V’S 2022) ($MN)
Figure 21 ADULT CELL GLOBAL MARKET, BY TYPE, (2015 V’S 2022) ($MN)
Figure 22 CELL EXPANSION GLOBAL MARKET, BY APPLICATION, (2014-2022) ($MN)
Figure 23 CELL EXPANSION GLOBAL MARKET, BY END USERS, (2014-2022) ($MN)
Figure 24 CELL EXPANSION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Figure 25 NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY PRODUCTS, CELL TYPES, APPLICATIONS & END USERS, (2015 V’S 2022) ($MN)
Figure 26 EUROPE CELL EXPANSION MARKET REVENUE, BY PRODUCTS, CELL TYPES, APPLICATIONS & END USERS, (2015 V’S 2022) ($MN)
Figure 27 ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY PRODUCTS, CELL TYPES, APPLICATIONS & BY END USERS, (2015 V’S 2022) ($MN)
Figure 28 ROW CELL EXPANSION MARKET REVENUE, BY PRODUCTS, CELL TYPES, APPLICATIONS, END USERS (2015 V’S 2022) ($MN)
Figure 29 KEY GROWTH STRATEGIES (2014-2016)
Figure 30 NEW PRODUCT LAUNCH (2014-2016)
Figure 31 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES (2014-2016)
Figure 32 SWOT: BECTON, DICKINSON AND COMPANY
Figure 33 SWOT: CORNING, INC.
Figure 34 SWOT: DANAHER CORPORATION
Figure 35 SWOT: EPPENDORF AG
Figure 36 SWOT: GE HEALTHCARE
Figure 37 SWOT: LONZA GROUP LTD.
Figure 38 SWOT: MERCK KGAA
Figure 39 SWOT: MILTENYI BIOTEC
Figure 40 SWOT: STEMCELL TECHNOLOGIES
Figure 41 SWOT: TERUMO CORPORATION
Figure 42 SWOT: THERMO FISHER SCIENTIFIC
Figure 1 CELL EXPANSION GLOBAL MARKET, BY REGION (2014-2022) ($MN)
Figure 2 RESEARCH METHODOLOGY: CELL EXPANSION GLOBAL MARKET
Figure 3 CELL EXPANSION GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 CELL EXPANSION GLOBAL MARKET: FORECASTING MODEL
Figure 5 CELL EXPANSION GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
Figure 6 CELL EXPANSION GLOBAL MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 CELL EXPANSION GLOBAL MARKET: PORTER’S ANALYSIS
Figure 9 CELL EXPANSION GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
Figure 10 CELL EXPANSION GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015, (%)
Figure 11 SINGLE-USE BIOREACTOR MARKET REVENUE, BY MAJOR PLAYERS, 2015, (%)
Figure 12 CELL EXPANSION GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
Figure 13 CELL EXPANSION GLOBAL MARKET, BY PRODUCTS, (2014-2022) ($MN)
Figure 14 CELL EXPANSION INSTRUMENTS GLOBAL MARKET, BY TYPE, (2014-2022) ($MN)
Figure 15 CELL EXPANSION SUPPORTING EQUIPMENTSS GLOBAL MARKET, BY TYPE (2014-2022) ($MN)
Figure 16 CELL EXPANSION BIOREACTORS GLOBAL MARKET, BY TYPE, (2015 V’S 2022), ($MN)
Figure 17 CELL EXPANSION CONSUMABLES GLOBAL MARKET, BY TYPE, (2014-2022), ($MN)
Figure 18 CELL EXPANSION DISPOSABLES GLOBAL MARKET, BY TYPE, (2014-2022) ($MN)
Figure 19 CELL EXPANSION GLOBAL MARKET, BY CELL TYPES, (2015 V’S 2022) ($MN)
Figure 20 HUMAN CELL GLOBAL MARKET, BY TYPE, (2015 V’S 2022) ($MN)
Figure 21 ADULT CELL GLOBAL MARKET, BY TYPE, (2015 V’S 2022) ($MN)
Figure 22 CELL EXPANSION GLOBAL MARKET, BY APPLICATION, (2014-2022) ($MN)
Figure 23 CELL EXPANSION GLOBAL MARKET, BY END USERS, (2014-2022) ($MN)
Figure 24 CELL EXPANSION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Figure 25 NORTH AMERICA CELL EXPANSION MARKET REVENUE, BY PRODUCTS, CELL TYPES, APPLICATIONS & END USERS, (2015 V’S 2022) ($MN)
Figure 26 EUROPE CELL EXPANSION MARKET REVENUE, BY PRODUCTS, CELL TYPES, APPLICATIONS & END USERS, (2015 V’S 2022) ($MN)
Figure 27 ASIA PACIFIC CELL EXPANSION MARKET REVENUE, BY PRODUCTS, CELL TYPES, APPLICATIONS & BY END USERS, (2015 V’S 2022) ($MN)
Figure 28 ROW CELL EXPANSION MARKET REVENUE, BY PRODUCTS, CELL TYPES, APPLICATIONS, END USERS (2015 V’S 2022) ($MN)
Figure 29 KEY GROWTH STRATEGIES (2014-2016)
Figure 30 NEW PRODUCT LAUNCH (2014-2016)
Figure 31 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES (2014-2016)
Figure 32 SWOT: BECTON, DICKINSON AND COMPANY
Figure 33 SWOT: CORNING, INC.
Figure 34 SWOT: DANAHER CORPORATION
Figure 35 SWOT: EPPENDORF AG
Figure 36 SWOT: GE HEALTHCARE
Figure 37 SWOT: LONZA GROUP LTD.
Figure 38 SWOT: MERCK KGAA
Figure 39 SWOT: MILTENYI BIOTEC
Figure 40 SWOT: STEMCELL TECHNOLOGIES
Figure 41 SWOT: TERUMO CORPORATION
Figure 42 SWOT: THERMO FISHER SCIENTIFIC
